טמו 20 מג Israel - Hebräisch - Ministry of Health

טמו 20 מג

padagis israel agencies ltd, israel - temozolomide - קפסולות - temozolomide 20 mg - temozolomide - temozolomide - temo capsules are indicated for the treatment of patients with malignant glioma such as glioblastoma multiforme or anaplastic astrocytoma, showing recurrence or progression after standard therapy. temo capsules are also indicated as first line treatment for patients with advanced metastatic malignant melanoma. newly diagnosed glioblastoma multiforme concomitantly with radiotherapy and subsequently as monotherapy treatment.

טמו 20 מג Israel - Hebräisch - Ministry of Health

טמו 20 מג

padagis israel agencies ltd, israel - temozolomide - קפסולות - temozolomide 20 mg - temozolomide - temozolomide - temo capsules are indicated for the treatment of patients with malignant glioma such as glioblastoma multiforme or anaplastic astrocytoma, showing recurrence or progression after standard therapy. temo capsules are also indicated as first line treatment for patients with advanced metastatic malignant melanoma. newly diagnosed glioblastoma multiforme concomitantly with radiotherapy and subsequently as monotherapy treatment.

טמו 100 מג Israel - Hebräisch - Ministry of Health

טמו 100 מג

padagis israel agencies ltd, israel - temozolomide - קפסולות - temozolomide 100 mg - temozolomide - temozolomide - temo capsules are indicated for the treatment of patients with malignant glioma such as glioblastoma multiforme or anaplastic astrocytoma, showing recurrence or progression after standard therapy. temo capsules are also indicated as first line treatment for patients with advanced metastatic malignant melanoma. newly diagnosed glioblastoma multiforme concomitantly with radiotherapy and subsequently as monotherapy treatment.

טמו 100 מג Israel - Hebräisch - Ministry of Health

טמו 100 מג

padagis israel agencies ltd, israel - temozolomide - קפסולות - temozolomide 100 mg - temozolomide - temozolomide - temo capsules are indicated for the treatment of patients with malignant glioma such as glioblastoma multiforme or anaplastic astrocytoma, showing recurrence or progression after standard therapy. temo capsules are also indicated as first line treatment for patients with advanced metastatic malignant melanoma. newly diagnosed glioblastoma multiforme concomitantly with radiotherapy and subsequently as monotherapy treatment.

טמו 140 מג Israel - Hebräisch - Ministry of Health

טמו 140 מג

perrigo israel agencies ltd, israel - temozolomide - קפסולות - temozolomide 140 mg - temozolomide - temozolomide - temo capsules are indicated for the treatment of patients with malignant glioma such as glioblastoma multiforme or anaplastic astrocytoma, showing recurrence or progression after standard therapy. temo capsules are also indicated as first line treatment for patients with advanced metastatic malignant melanoma. newly diagnosed glioblastoma multiforme concomitantly with radiotherapy and subsequently as monotherapy treatment.

טמו 140 מג Israel - Hebräisch - Ministry of Health

טמו 140 מג

perrigo israel agencies ltd, israel - temozolomide - קפסולות - temozolomide 140 mg - temozolomide - temozolomide - temo capsules are indicated for the treatment of patients with malignant glioma such as glioblastoma multiforme or anaplastic astrocytoma, showing recurrence or progression after standard therapy. temo capsules are also indicated as first line treatment for patients with advanced metastatic malignant melanoma. newly diagnosed glioblastoma multiforme concomitantly with radiotherapy and subsequently as monotherapy treatment.

טמו 180 מ"ג Israel - Hebräisch - Ministry of Health

טמו 180 מ"ג

perrigo israel agencies ltd - temozolomide 180 mg - capsules - temozolomide - temo capsules are indicated for the treatment of patients with malignant glioma such as glioblastoma multiforme or anaplastic astrocytoma, showing recurrence or progression after standard therapy. temo capsules are also indicated as first line treatment for patients with advanced metastatic malignant melanoma. newly diagnosed glioblastoma multiforme concomitantly with radiotherapy and subsequently as monotherapy treatment.

טמו 250 מג Israel - Hebräisch - Ministry of Health

טמו 250 מג

padagis israel agencies ltd, israel - temozolomide - קפסולות - temozolomide 250 mg - temozolomide - temozolomide - temo capsules are indicated for the treatment of patients with malignant glioma such as glioblastoma multiforme or anaplastic astrocytoma, showing recurrence or progression after standard therapy. temo capsules are also indicated as first line treatment for patients with advanced metastatic malignant melanoma. newly diagnosed glioblastoma multiforme concomitantly with radiotherapy and subsequently as monotherapy treatment.

טמו 250 מג Israel - Hebräisch - Ministry of Health

טמו 250 מג

padagis israel agencies ltd, israel - temozolomide - קפסולות - temozolomide 250 mg - temozolomide - temozolomide - temo capsules are indicated for the treatment of patients with malignant glioma such as glioblastoma multiforme or anaplastic astrocytoma, showing recurrence or progression after standard therapy. temo capsules are also indicated as first line treatment for patients with advanced metastatic malignant melanoma. newly diagnosed glioblastoma multiforme concomitantly with radiotherapy and subsequently as monotherapy treatment.

דקרבזין מדאק 200 מג Israel - Hebräisch - Ministry of Health

דקרבזין מדאק 200 מג

tzamal bio-pharma ltd - dacarbazine as citrate - אבקה להמסה להזרקה\אינפוזיה - dacarbazine as citrate 200 mg/vial - dacarbazine - dacarbazine - decarbazine is indicated for the treatment of patients with metastatic malignant melanoma. further indications for dacarbazine as part of a combination chemotherapy in advanced hodgkin's disease as a second line.